Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 30 May 2025 | 26 Mar 2025 |
Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the financial year ended March 31 2025 Outcome of Board Meeting held today (As per BSE Announcement Dated on 30/05/2025) | ||
Board Meeting | 14 Feb 2025 | 31 Dec 2024 |
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Un-audited financial results of the company for the quarter ended December 31 2024 The Board has considered and took on record the Un-audited Financial Results for the quarter ended December 31, 2024 Due to inadvertence, the start & end time of Board meeting was input in Indian time (02:00 To 03:30) instead of international time zone (14:00 To 15:30). The correct date & time of board meeting is as under: Date of board meeting: 14-02-2025 Commencement time: 14:00 hrs End time: 15:30 hrs Due to inadvertence, the start and end time of the Board Meeting held today was input in Indian time (02:00 to 03:30) instead of international time zone (14:00 to 15:30) during the filing of outcome of board meeting under corporate announcements. Correct Start & End time is: Start: 14:00 hrs End: 15:30 hrs (As Per BSE Announcement Dated on 14.02.2025) | ||
Board Meeting | 14 Nov 2024 | 27 Sep 2024 |
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Un-Audited Financial results of the company for the quarter and half year ended September 30 2024 Un-audited financial results for the quarter and half year ended September 30, 2024 (As per BSE Announcement dated on 14/11/2024) | ||
Board Meeting | 13 Aug 2024 | 29 Jun 2024 |
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended June 30 2024. The Board has considered and took on record the Un-audited Financial Results for the quarter ended June 30, 2024. (As Per BSE Announcement Dated on: 13/08/2024) | ||
Board Meeting | 23 Jul 2024 | 25 Jul 2024 |
Appointment of Mr. Manishkumar Indukumar Pipalia and Mr. Sachin Samir Kothary as Non-Executive Independent Directors of the Company for a term of 5 consecutive years each with effect from July 23, 2024, subject to approval of the shareholders at the forthcoming 32nd AGM |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.